Addus EVP sells shares, gets stock award

Addus HomeCare Corp EVP and Chief Legal Officer Sean Gaffney reported two stock transactions.

Rhea-AI Filing Summary

Addus HomeCare Corp EVP and Chief Legal Officer Sean Gaffney reported two stock transactions. He received a grant of 3,897 common shares at no cost, vesting in three equal installments on February 20 of 2027, 2028, and 2029. He then executed an open-market sale of 737 shares at $114.91 under a pre-established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, leaving him with 21,339 directly held shares.

Insider Trade Summary

Net Seller: 737 shares

Net Sell 2 txns

Insider GAFFNEY SEAN

Role EVP, Chief Legal Officer

Sold 737 shs ($85K)

Type	Security	Shares	Price	Value
Sale	Common Stock	737	$114.91	$85K
Grant/Award	Common Stock	3,897	$0.00	$0.00

Holdings After Transaction: Common Stock — 21,339 shares (Direct)

Footnotes (3)

1. F1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control.
2. F2. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.
3. F3. Adoption date of referenced 10b5-1(c) plan is: 03/07/2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Addus HomeCare (ADUS) report for Sean Gaffney?

Sean Gaffney reported a stock grant of 3,897 Addus HomeCare shares and an open-market sale of 737 shares. The grant was at no cost, while the sale occurred at $114.91 per share under a pre-set 10b5-1 trading plan.

How many Addus (ADUS) shares did Sean Gaffney sell and at what price?

Sean Gaffney sold 737 shares of Addus common stock at $114.91 per share. The filing notes this sale was executed under a previously established Rule 10b5-1 plan to satisfy tax obligations from vesting restricted stock awards.

What stock award did Sean Gaffney receive from Addus HomeCare (ADUS)?

Sean Gaffney received a grant of 3,897 shares of Addus common stock at no purchase price. These shares vest in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029, subject to continued service and change-in-control provisions.

Why did Sean Gaffney’s Addus (ADUS) 10b5-1 plan trigger a stock sale?

The filing states the 737-share sale was made under a previously established Rule 10b5-1 plan. The purpose was to satisfy tax obligations arising from the vesting of restricted stock awards that Addus HomeCare had granted to Sean Gaffney.

How many Addus HomeCare (ADUS) shares does Sean Gaffney hold after these transactions?

After the reported grant and sale, Sean Gaffney directly holds 21,339 shares of Addus common stock. The ownership is reported as direct, with no indication of indirect entities or separate voting or investment authority in the provided disclosure.

When do Sean Gaffney’s newly granted Addus (ADUS) shares vest?

The 3,897-share award vests in three equal installments on February 20, 2027, February 20, 2028, and February 20, 2029. Vesting is subject to customary conditions, including continued service and potential acceleration upon a change in control of Addus HomeCare.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:01 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GAFFNEY SEAN

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/20/2026		A		3,897(1)	A	$0	22,076	D
Common Stock	02/23/2026		S(2)(3)		737	D	$114.91	21,339	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares vest in equal installments on each of February 20, 2027, February 20, 2028, and February 20, 2029, subject to customary provisions for continued service and acceleration on a change in control.

2. This transaction reflects the sale of shares, made pursuant to a previously established 10b5-1 plan, for the purpose of satisfying tax obligations due upon the vesting of restricted stock awards granted by the Issuer.

3. Adoption date of referenced 10b5-1(c) plan is: 03/07/2025

	/s/ Brian Poff, Attorney-in-Fact for Sean Gaffney	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.